XML 23 R13.htm IDEA: XBRL DOCUMENT
v3.19.2

FAIR VALUE | 6 Months Ended
--- | ---
Jun. 30, 2019
FAIR VALUE. |
FAIR VALUE | 5. FAIR VALUE The Company adopted Accounting Standards Update (“ASU”) 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities during the first quarter of 2018. The Company adopted the amended guidance that requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes. FASB ASC No. 820‑10 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. FASB ASC 820‑10 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair values: Level 1: Quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access as of the measurement date. Level 2: Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data. Level 3: Significant unobservable inputs that reflect a reporting entity's own assumptions about the assumptions that market participants would use in pricing an asset or liability. The following tables summarize assets and liabilities measured at fair value on a recurring basis:
|  | June 30, 2019
|  |  |  | Fair Value Measurements Using:
|  |  |  | Quoted Prices |  |  |  |
|  |  |  | In Active |  | Significant |  |
|  |  |  | Markets for |  | Other |  | Significant
|  |  |  | Identical |  | Observable |  | Unobservable
|  | Carrying |  | Assets |  | Inputs |  | Inputs
(In thousands) |  | Value |  | (Level 1) |  | (Level 2) |  | (Level 3)
Financial assets: |  |  |  |  |  |  |  |  |  |
Available for sale securities: |  |  |  |  |  |  |  |  |  |
U.S. GSE securities |  | $ | 14,963 |  |  |  | $ | 14,963 |  |
State and municipal obligations |  |  | 28,748 |  |  |  |  | 28,748 |  |
U.S. GSE residential mortgage-backed securities |  |  | 93,257 |  |  |  |  | 93,257 |  |
U.S. GSE residential collateralized mortgage obligations |  |  | 333,784 |  |  |  |  | 333,784 |  |
U.S. GSE commercial mortgage-backed securities |  |  | 7,051 |  |  |  |  | 7,051 |  |
U.S. GSE commercial collateralized mortgage obligations |  |  | 98,397 |  |  |  |  | 98,397 |  |
Other asset-backed securities |  |  | 23,462 |  |  |  |  | 23,462 |  |
Corporate bonds |  |  | 43,235 |  |  |  |  | 43,235 |  |
Total available for sale securities |  | $ | 642,897 |  |  |  | $ | 642,897 |  |
Derivatives |  | $ | 11,919 |  |  |  | $ | 11,919 |  |
Financial liabilities: |  |  |  |  |  |  |  |  |  |
Derivatives |  | $ | 13,594 |  |  |  | $ | 13,594 |  |
|  | December 31, 2018
|  |  |  | Fair Value Measurements Using:
|  |  |  | Quoted Prices |  |  |  |
|  |  |  | In Active |  | Significant |  |
|  |  |  | Markets for |  | Other |  | Significant
|  |  |  | Identical |  | Observable |  | Unobservable
|  | Carrying |  | Assets |  | Inputs |  | Inputs
(In thousands) |  | Value |  | (Level 1) |  | (Level 2) |  | (Level 3)
Financial assets: |  |  |  |  |  |  |  |  |  |
Available for sale securities: |  |  |  |  |  |  |  |  |  |
U.S. GSE securities |  | $ | 29,050 |  |  |  | $ | 29,050 |  |
State and municipal obligations |  |  | 40,731 |  |  |  |  | 40,731 |  |
U.S. GSE residential mortgage-backed securities |  |  | 93,538 |  |  |  |  | 93,538 |  |
U.S. GSE residential collateralized mortgage obligations |  |  | 357,777 |  |  |  |  | 357,777 |  |
U.S. GSE commercial mortgage-backed securities |  |  | 3,508 |  |  |  |  | 3,508 |  |
U.S. GSE commercial collateralized mortgage obligations |  |  | 90,638 |  |  |  |  | 90,638 |  |
Other asset-backed securities |  |  | 23,219 |  |  |  |  | 23,219 |  |
Corporate bonds |  |  | 42,425 |  |  |  |  | 42,425 |  |
Total available for sale securities |  | $ | 680,886 |  |  |  | $ | 680,886 |  |
Derivatives |  | $ | 6,363 |  |  |  | $ | 6,363 |  |
Financial liabilities: |  |  |  |  |  |  |  |  |  |
Derivatives |  | $ | 2,215 |  |  |  | $ | 2,215 |  |
The following tables summarize assets measured at fair value on a non-recurring basis:
|  | June 30, 2019
|  |  |  | Fair Value Measurements Using:
|  |  |  | Quoted Prices |  |  |  |
|  |  |  | In Active |  | Significant |  |
|  |  |  | Markets for |  | Other |  | Significant
|  |  |  | Identical |  | Observable |  | Unobservable
|  | Carrying |  | Assets |  | Inputs |  | Inputs
(In thousands) |  | Value |  | (Level 1) |  | (Level 2) |  | (Level 3)
Loans held for sale |  | $ | 12,643 |  |  | $ | 12,643 |  |  |
Impaired loans |  | $ | 4,791 |  |  |  |  |  | $ | 4,791
|  | December 31, 2018
|  |  |  | Fair Value Measurements Using:
|  |  |  | Quoted Prices |  |  |  |
|  |  |  | In Active |  | Significant |  |
|  |  |  | Markets for |  | Other |  | Significant
|  |  |  | Identical |  | Observable |  | Unobservable
|  | Carrying |  | Assets |  | Inputs |  | Inputs
(In thousands) |  | Value |  | (Level 1) |  | (Level 2) |  | (Level 3)
Impaired loans |  | $ | 2,532 |  |  |  |  |  | $ | 2,532
Other real estate owned |  | $ | 175 |  |  |  |  |  | $ | 175
Impaired loans with an allocated allowance for loan losses at June 30, 2019 had a carrying amount of $4.8 million, which is made up of the outstanding balance of $5.5 million, net of a valuation allowance of $0.7 million. This resulted in an additional provision for loan losses of $0.5 million that is included in the amount reported on the consolidated statements of income for the six months ended June 30, 2019. Impaired loans with an allocated allowance for loan losses at December 31, 2018 had a carrying amount of $2.5 million, which is made up of the outstanding balance of $2.7 million, net of a valuation allowance of $0.2 million. This resulted in an additional provision for loan losses of $0.2 million that is included in the amount reported on the consolidated statements of income for the year ended December 31, 2018. There was no other real estate owned at June 30, 2019. At December 31, 2018, other real estate owned had a carrying amount of $0.2 million with no valuation allowance recorded. Accordingly, there was no additional provision for loan losses included in the amount reported on the consolidated statements of income. The Company used the following methods and assumptions in estimating the fair value of its financial instruments: Securities Available for Sale and Held to Maturity: If available, the estimated fair values are based on independent dealer quotations on nationally recognized securities exchanges and are classified as Level 1. For securities where quoted prices are not available, fair value is based on matrix pricing, which is a mathematical technique widely used in the industry to value debt securities without relying exclusively on quoted prices for the specific securities but rather by relying on the securities' relationship to other benchmark quoted securities resulting in a Level 2 classification. Derivatives: Represents interest rate swaps for which the estimated fair values are based on valuation models using observable market data as of the measurement date resulting in a Level 2 classification. Loans Held for Sale: Loans held for sale are carried at the lower of cost or fair value. The fair value of loans held for sale is determined using the price we expect to receive for the loans based on commitments received from third-party investors, resulting in a Level 2 classification. Impaired Loans and Other Real Estate Owned: For impaired loans, the Company evaluates the fair value of the loan in accordance with current accounting guidance. For loans that are collateral dependent, the fair value of the collateral is used to determine the fair value of the loan. The fair value of the collateral is determined based on recent appraised values. The fair value of other real estate owned is also evaluated in accordance with current accounting guidance and determined based on recent appraised values less the estimated cost to sell. These appraisals may utilize a single valuation approach or a combination of approaches including comparable sales and the income approach. Adjustments are routinely made in the appraisal process by the independent appraisers to adjust for differences between the comparable sales and income data available. Adjustments may relate to location, square footage, condition, amenities, market rate of leases as well as timing of comparable sales. All appraisals undergo a second review process to ensure that the methodology employed, and the values derived are reasonable. The fair value of the loan is compared to the carrying value to determine if any write-down or specific reserve is required. Impaired loans are evaluated quarterly for additional impairment and adjusted accordingly. Appraisals for collateral-dependent impaired loans are performed by certified general appraisers (for commercial properties) or certified residential appraisers (for residential properties) whose qualifications and licenses have been reviewed and verified by the Company. Once received, the Credit Department reviews the assumptions and approaches utilized in the appraisal as well as the overall resulting fair value in comparison with independent data sources such as recent market data or industry-wide statistics. Management also considers the appraisal values for commercial properties associated with current loan origination activity. Collectively, this information is reviewed to help assess current trends in commercial property values. For each collateral dependent impaired loan, management considers information that relates to the type of commercial property to determine if such properties may have appreciated or depreciated in value since the date of the most recent appraisal. Adjustments to fair value are made only when the analysis indicates a probable decline in collateral values. Adjustments made in the appraisal process are not deemed material to the overall consolidated financial statements given the level of impaired loans measured at fair value on a nonrecurring basis. The following tables summarize the estimated fair values and recorded carrying amounts of the Company's financial instruments at June 30, 2019 and December 31, 2018:
|  | June 30, 2019
|  |  |  | Fair Value Measurements Using: |  |
|  |  |  |  |  | Significant |  |  |  |
|  |  |  | Quoted Prices In |  | Other |  | Significant |  |
|  |  |  | Active Markets for |  | Observable |  | Unobservable |  |
|  | Carrying |  | Identical Assets |  | Inputs |  | Inputs |  | Total
(In thousands) |  | Amount |  | (Level 1) |  | (Level 2) |  | (Level 3) |  | Fair Value
Financial assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and due from banks |  | $ | 71,292 |  | $ | 71,292 |  | $ | — |  | $ | — |  | $ | 71,292
Interest-bearing deposits with banks |  |  | 87,349 |  |  | 87,349 |  |  | — |  |  | — |  |  | 87,349
Securities available for sale |  |  | 642,897 |  |  | — |  |  | 642,897 |  |  | — |  |  | 642,897
Securities restricted |  |  | 24,104 |  |  | n/a |  |  | n/a |  |  | n/a |  |  | n/a
Securities held to maturity |  |  | 144,716 |  |  | — |  |  | 145,480 |  |  | — |  |  | 145,480
Loans held for sale |  |  | 12,643 |  |  | — |  |  | 12,643 |  |  | — |  |  | 12,643
Loans, net |  |  | 3,398,852 |  |  | — |  |  | — |  |  | 3,375,662 |  |  | 3,375,662
Derivatives |  |  | 11,919 |  |  | — |  |  | 11,919 |  |  | — |  |  | 11,919
Accrued interest receivable |  |  | 12,397 |  |  | — |  |  | 2,532 |  |  | 9,865 |  |  | 12,397
Financial liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Certificates of deposit |  |  | 276,921 |  |  | — |  |  | 276,929 |  |  | — |  |  | 276,929
Demand and other deposits |  |  | 3,559,655 |  |  | 3,559,655 |  |  | — |  |  | — |  |  | 3,559,655
FHLB advances |  |  | 240,000 |  |  | — |  |  | 240,206 |  |  | — |  |  | 240,206
Repurchase agreements |  |  | 945 |  |  | — |  |  | 945 |  |  | — |  |  | 945
Subordinated debentures |  |  | 78,850 |  |  | — |  |  | 80,668 |  |  | — |  |  | 80,668
Derivatives |  |  | 13,594 |  |  | — |  |  | 13,594 |  |  | — |  |  | 13,594
Accrued interest payable |  |  | 1,718 |  |  | — |  |  | 1,718 |  |  | — |  |  | 1,718
|  | December 31, 2018
|  |  |  | Fair Value Measurements Using: |  |
|  |  |  |  |  | Significant |  |  |  |
|  |  |  | Quoted Prices In |  | Other |  | Significant |  |
|  |  |  | Active Markets for |  | Observable |  | Unobservable |  |
|  | Carrying |  | Identical Assets |  | Inputs |  | Inputs |  | Total
(In thousands) |  | Amount |  | (Level 1) |  | (Level 2) |  | (Level 3) |  | Fair Value
Financial assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and due from banks |  | $ | 142,145 |  | $ | 142,145 |  | $ | — |  | $ | — |  | $ | 142,145
Interest-bearing deposits with banks |  |  | 153,223 |  |  | 153,223 |  |  | — |  |  | — |  |  | 153,223
Securities available for sale |  |  | 680,886 |  |  | — |  |  | 680,886 |  |  | — |  |  | 680,886
Securities restricted |  |  | 24,028 |  |  | n/a |  |  | n/a |  |  | n/a |  |  | n/a
Securities held to maturity |  |  | 160,163 |  |  | — |  |  | 156,792 |  |  | — |  |  | 156,792
Loans, net |  |  | 3,244,393 |  |  | — |  |  | — |  |  | 3,216,204 |  |  | 3,216,204
Derivatives |  |  | 6,363 |  |  | — |  |  | 6,363 |  |  | — |  |  | 6,363
Accrued interest receivable |  |  | 11,236 |  |  | — |  |  | 2,936 |  |  | 8,300 |  |  | 11,236
Financial liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Certificates of deposit |  |  | 329,491 |  |  | — |  |  | 326,865 |  |  | — |  |  | 326,865
Demand and other deposits |  |  | 3,556,902 |  |  | 3,556,902 |  |  | — |  |  | — |  |  | 3,556,902
FHLB advances |  |  | 240,433 |  |  | — |  |  | 236,209 |  |  | — |  |  | 236,209
Repurchase agreements |  |  | 539 |  |  | — |  |  | 539 |  |  | — |  |  | 539
Subordinated debentures |  |  | 78,781 |  |  | — |  |  | 74,400 |  |  | — |  |  | 74,400
Derivatives |  |  | 2,215 |  |  | — |  |  | 2,215 |  |  | — |  |  | 2,215
Accrued interest payable |  |  | 1,524 |  |  | — |  |  | 1,524 |  |  | — |  |  | 1,524

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration